Tower Research Capital (TRC)’s Clarus Therapeutics Holdings, Inc. Common Stock CRXT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-620
Closed 6910
2022
Q2
$0 Sell
620
-3,316
-84% ﹤0.01% 6983
2022
Q1
$6K Sell
3,936
-8,987
-70% -$13.7K ﹤0.01% 4998
2021
Q4
$31K Sell
12,923
-30,422
-70% -$73K ﹤0.01% 3206
2021
Q3
$231K Buy
+43,345
New +$231K 0.01% 1683